Cargando…
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
BACKGROUND: It has been recognized that primary membranous nephropathy (MN) is related to an increased risk for thromboembolic complications. However, the current evidence supporting prophylactic and therapeutic anticoagulation is too weak to better meet the clinical needs of this patient population...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889582/ https://www.ncbi.nlm.nih.gov/pubmed/31791286 http://dx.doi.org/10.1186/s12882-019-1637-y |